Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2026-03-01 @ 12:05 PM
Study NCT ID:
NCT00550004
Status:
TERMINATED
Last Update Posted:
2011-06-08
First Post:
2007-10-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine
Sponsor:
SciClone Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pancreatic Cancer | View |